The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology

Diabetes and Vascular Disease Research

Volumn 11, Issue 6, 2014, Pages 410-418

  Shaw, Daniel James ^a   Seese, Rachel ^a   Ponnambalam, Sreenivasan ^a   Ajjan, Ramzi ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

atherosclerosis; cardiovascular disease; LOX 1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; FASUDIL; IMMUNOLIPOSOME; LIPOSOME; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; POLYAMIDE; PROCYANIDIN DERIVATIVE; PYRROLE IMIDAZOLE POLYAMIDE DERIVATIVE; SCAVENGER RECEPTOR; TECHNETIUM 99M; UNCLASSIFIED DRUG; OLR1 PROTEIN, HUMAN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; GENETIC MANIPULATION; HUMAN; ISOTOPE LABELING; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; THROMBOSIS; VASCULAR DISEASE; ANIMAL; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; ATHEROSCLEROSIS; HUMANS; MOLECULAR TARGETED THERAPY; SCAVENGER RECEPTORS, CLASS E; THROMBOSIS;

EID: 84912038449     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114547704     Document Type: Review

References (57)

1. Poole-Wilson P Cardiovascular medicine. Willerson J Wellens HJ Cohn J, ed. London: Springer ; 2007: 653-658.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 ; 362: 801-809
3. Xu S, Ogura S, Chen J, et al. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci. 2013 ; 70: 2859-2872
4. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997 ; 386: 73-77
5. Yamanaka S, Zhang XY, Miura K, et al. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics. 1998 ; 54: 191-199
6. Xie Q, Matsunaga S, Niimi S, et al. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol. 2004 ; 23: 111-117
7. Ishigaki T, Ohki I, Utsunomiya-Tate N, et al. Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1). J Biochem. 2007 ; 141: 855-866
8. Murase T, Kume N, Kataoka H, et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol. 2000 ; 20: 715-720
9. Yoshida H, Kondratenko N, Green S, et al. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J. 1998 ; 334: 9-13
10. Kataoka H, Kume N, Miyamoto S, et al. Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001 ; 21: 955-960
11. Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013 ; 2013: 152786
12. Delneste Y, Magistrelli G, Gauchat J, et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity. 2002 ; 17: 353-362
13. Jiang J, Yan M, Mehta JL, et al. Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1. Cardiovasc Drugs Ther. 2011 ; 25: 461-468
14. Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A. 1998 ; 95: 9535-9540
15. Bruneau N, Richard S, Silvy F, et al. Lectin-like Ox-LDL receptor is expressed in human INT-407 intestinal cells: involvement in the transcytosis of pancreatic bile salt-dependent lipase. Mol Biol Cell. 2003 ; 14: 2861-2875
16. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol. 2002 ; 39: 1429-1435
17. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol. 2000 ; 20: 1116-1122
18. Skalen K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002 ; 417: 750-754
19. Mattaliano MD, Huard C, Cao W, et al. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol. 2009 ; 296: C1329 - C1337
20. Takei A, Huang Y, Lopes-Virella MF. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis. 2001 ; 154: 79-86
21. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000 ; 101: 2889-2895
22. Rios FJ, Ferracini M, Pecenin M, et al. Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts. PLoS one. 2013 ; 8: e76893
23. Marwali MR, Hu CP, Mohandas B, et al. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther. 2007 ; 322: 1324-1332
24. Mango R, Clementi F, Borgiani P, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet. 2003 ; 40: 933-936
25. Biocca S, Filesi I, Mango R, et al. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J Mol Cell Cardiol. 2008 ; 44: 561-570
26. Biocca S, Falconi M, Filesi I, et al. Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS one. 2009 ; 4: e4648
27. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun. 2003 ; 303: 247-250
28. Chen Q, Reis SE, Kammerer C, et al. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation. 2003 ; 107: 3146-3151
29. Mango R, Biocca S, del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res. 2005 ; 97: 152-158
30. Mango R, Predazzi IM, Romeo F, et al. LOX-1/LOXIN: the yin/yang of atheroscleorosis. Cardiovasc Drugs Ther. 2011 ; 25: 489-494
31. Inoue K, Arai Y, Kurihara H, et al. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res. 2005 ; 97: 176-184
32. Mehta JL, Sanada N, Hu CP, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007 ; 100: 1634-1642
33. Hu C, Dandapat A, Sun L, et al. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res. 2008 ; 79: 287-293
34. Dias N, Stein CA. Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther. 2002 ; 1: 347-355
35. Hu B, Li D, Sawamura T, et al. Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells. Biochem Biophys Res Commun. 2003 ; 307: 1008-1012
36. Amati F, Diano L, Vecchione L, et al. LOX-1 inhibition in ApoE KO mice using a Schizophyllan-based Antisense Oligonucleotide Therapy. Mol Ther Nucleic Acids. 2012 ; 1: e58
37. Trauger JW, Baird EE, Dervan PB. Extended hairpin polyamide motif for sequence-specific recognition in the minor groove of DNA. Chem Biol. 1996 ; 3: 369-377
38. Ueno T, Fukuda N, Tsunemi A, et al. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function. J Hypertens. 2009 ; 27: 508-516
39. Dalen JE, Devries S. Diets to prevent coronary heart disease 1957-2013: what have we learned?. Am J Med. 2014 ; 127: 364-369
40. Nishizuka T, Fujita Y, Sato Y, et al. Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox. Proc Jpn Acad Ser B Phys Biol Sci. 2011 ; 87: 104-113
41. Holt RR, Heiss C, Kelm M, et al. The potential of flavanol and procyanidin intake to influence age-related vascular disease. J Nutr Gerontol Geriatr. 2012 ; 31: 290-323
42. Syder AJ, Lee H, Zeisel MB, et al. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. J Hepatol. 2011 ; 54: 48-55
43. Matsumoto T, Fujita M, Sawamura T, et al. Pitavastatin reduces lectin-like oxidized low-density lipoprotein receptor-1 ligands in hypercholesterolemic humans. Lipids. 2010 ; 45: 329-335
44. Chen H, Li D, Saldeen T, et al. Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ Res. 2001 ; 89: 1155-1160
45. Sugimoto K, Ishibashi T, Sawamura T, et al. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res. 2009 ; 84: 127-136
46. Ishino S, Mukai T, Kuge Y, et al. Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med. 2008 ; 49: 1677-1685
47. Li D, Patel AR, Klibanov AL, et al. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging. 2010 ; 3: 464-472
48. Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010 ; 30: 1282-1292
49. Li DY, Chen HJ, Staples ED, et al. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther. 2002 ; 7: 147-153
50. Ishino S, Mukai T, Kume N, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability - analysis in hypercholesterolemic rabbits. Atherosclerosis. 2007 ; 195: 48-56
51. Biocca S, Arcangeli T, Tagliaferri E, et al. Simulative and experimental investigation on the cleavage site that generates the soluble human LOX-1. Arch Biochem Biophys. 2013 ; 540: 9-18
52. Pirillo A, Catapano AL. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers. 2013 ; 35: 413-418
53. Hayashida K, Kume N, Murase T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005 ; 112: 812-818
54. Li D, Liu L, Chen H, et al. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation. 2003 ; 107: 612-617
55. Kobayashi N, Takano M, Hata N, et al. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography. Int J Cardiol. 2013 ; 168: 3217-3223
56. Kataoka H, Kume N, Miyamoto S, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999 ; 99: 3110-3117
57. Akagi M, Ueda A, Teramura T, et al. Oxidized LDL binding to LOX-1 enhances MCP-1 expression in cultured human articular chondrocytes. Osteoarthritis Cartilage. 2009 ; 17: 271-275